Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

RBM acquires biomarker research from Satoris for neurodegenerative disease testing

May 19, 2011

ERYtech and Teva sign long-term agreement on Graspa

May 18, 2011

Merck & Co. and Roche enter into nonexclusive agreements for hepatitis C therapies

May 18, 2011

Glenmark Pharmaceuticals grants sanofi-aventis license for GBR-500

May 17, 2011

Merus Labs acquires Vancocin from Iroko Pharmaceuticals

May 17, 2011

Clavis Pharma licenses anticancer candidate CP-4033 to Translational Therapeutics

May 16, 2011

Proteomika licenses HuCAL antibodies from AbD Serotec for use in Promonitor diagnostic kits

May 16, 2011

Tourette Syndrome Association and Psyadon Pharmaceuticals collaborate on ecopipam

May 16, 2011

BioFocus and Astellas Pharma sign target discovery agreement for CNS disorders

May 13, 2011

Halozyme and ViroPharma sign agreement to develop subcutaneous Cinryze formulation

May 12, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...